Scenic Biotech has joined the Michael J. Fox Foundation’s LRRK2 [...]

Porosome Therapeutics has reported preclinical results showing that restoring porosome [...]

Galimedix Therapeutics has completed a phase 1 study of its [...]

Accumulation of neurodegenerative proteins could be key to understanding bipolar [...]

The Rainwater Charitable Foundation, Aging Mind Foundation, Alzheimer’s Association, and [...]

AltPep Corporation has presented new preclinical findings at the Alzheimer’s [...]

Two new studies presented at the 2025 ISMRM Annual Meeting [...]

Chiesi Group has signed a worldwide license agreement with Swedish [...]

UK-based Alchemab Therapeutics has signed a landmark licensing agreement with [...]

Vesper Bio has reached a key enrolment milestone in its [...]